<code id='BE00D8B2DA'></code><style id='BE00D8B2DA'></style>
    • <acronym id='BE00D8B2DA'></acronym>
      <center id='BE00D8B2DA'><center id='BE00D8B2DA'><tfoot id='BE00D8B2DA'></tfoot></center><abbr id='BE00D8B2DA'><dir id='BE00D8B2DA'><tfoot id='BE00D8B2DA'></tfoot><noframes id='BE00D8B2DA'>

    • <optgroup id='BE00D8B2DA'><strike id='BE00D8B2DA'><sup id='BE00D8B2DA'></sup></strike><code id='BE00D8B2DA'></code></optgroup>
        1. <b id='BE00D8B2DA'><label id='BE00D8B2DA'><select id='BE00D8B2DA'><dt id='BE00D8B2DA'><span id='BE00D8B2DA'></span></dt></select></label></b><u id='BE00D8B2DA'></u>
          <i id='BE00D8B2DA'><strike id='BE00D8B2DA'><tt id='BE00D8B2DA'><pre id='BE00D8B2DA'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:7912

          Are venture capitalists OK? Are bolt-ons good for business? And when is it safe to say someone overpaid?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how biotech’s downturn has made life difficult not just for startups but also the VCs they rely on for much-needed funding. We also take a look at Gilead Sciences’ struggle to turn itself into an oncology company and the latest biotech to get bought out by a major pharma firm.

          advertisement

          For more on what we cover, here’s more on Gilead; here’s the news on Inhibrx; here’s the latest on biotech venture capital; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          knowledge

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          New Medicare drug pricing powers could soon be upended in court
          New Medicare drug pricing powers could soon be upended in court

          DistrictcourtswillmakethefirstroundofdecisionssoononchallengestoMedicare'sdrugpricenegotiationprogra

          read more
          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more

          The SUPPORT Act is critical to fighting the opioid crisis

          AdobeFewpublichealthchallengeshavebeenmoredauntingandpersistentthantheopioidcrisis,whichstartedbecau